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Melanotransferrin (MTf) has high sequence homology to
serum transferrin (Tf) (for review see [1]). However, unlike
other Tf family members, MTf is bound to the cell membrane
by a glycosyl-phosphatidylinositol (GPI) anchor [1]. For the
purpose of the present article, this well-described molecule will
be called MTf1. Tfs contain two high a⁄nity iron (Fe)-bind-
ing sites, and play a vital role in Fe transport [1]. However,
human MTf1 contains a single N-terminal Fe-binding site and
the membrane-bound molecule plays little role in Fe uptake
by melanoma cells [1].
Recent studies have suggested that MTf1 can be found
free in the serum of patients with various disease states, in-
cluding Alzheimer’s disease [2]. This important ¢nding has
prompted the question of whether there is a relationship
between the soluble form and the well-characterised mem-
brane-bound protein. It could be suggested that an alterna-
tive transcript of the MTf1 gene could encode a soluble
molecule, or the membrane-bound form may partition from
the membrane into the serum. In addition to these possibil-
ities, a second MTf-like gene could exist that encodes a related
protein that is soluble. Considering this, we examined the
GenBank sequence database for evidence of human MTf
sequences that could be indicative of a second gene or tran-
script.
Examination of this database led to the identi¢cation of
several nucleotide depositories of human MTf (see Table 1).
Review of both the nucleotide and protein sequence align-
ments revealed the presence of three di¡erent MTf cDNAs
that encode two protein products. In the present report, these
cDNAs have been denoted as the ‘long MTf cDNA’ (2364^
2607 bp; also called variant 1 by the National Centre for
Biotechnology Information (NCBI)) and the ‘short MTf
cDNA’ (1629^1664 bp; also called variant 2 by the NCBI)
(Table 1).
The long cDNA encodes the well-characterised membrane-
bound MTf1 molecule that is composed of 16 exons spanning
26 kb of genomic sequence (Fig. 1). Within the GenBank
database there are four entries for the long cDNA (Table
1). Three of these are 2.36 kb in length and are composed
of 16 exons, while another cDNA (GenBank XM_028281)
contains an additional 243 bp of 3P-untranslated region
(UTR) (Table 1). Review of the MTf1 genomic sequence
showed that this 243 bp region corresponds to an unreported
exon that we have called ‘16b’ (Fig. 1). Hence, the two long
transcripts di¡er from one another by the presence of an addi-
tional 3P-UTR in exon 16b, but both encode membrane-
bound MTf1.
In addition to the long transcripts, there are ¢ve entries in
GenBank that are recently discovered short MTf cDNAs (Ta-
ble 1). These cDNAs have nucleotide sequence lengths of
1629^1664 bp, the small di¡erences between these being due
to multiple transcription start sites and variation in length of
the poly(A) tail. All ¢ve cDNAs contain the ¢rst six exons of
the long MTf cDNA (Fig. 1) which encodes a large propor-
tion of the N-terminal lobe of MTf1. Further, in all of the
short MTf cDNAs, there is an additional 3P-sequence of 876
bp which is absent in the long cDNAs. Of this latter sequence,
only 195 bp are encoding amino acids. This additional 876 bp
of sequence was found to be a region within intron 6 of the
MTf1 gene between exons 6 and 7. We have denoted this new
exon as ‘6b’ (Fig. 1). This shows that both the long and short
MTf transcripts are the products of the well-known MTf1
gene, and could be due to alternative splicing. The protein
sequence derived from exon 6b results in a C-terminal that
shows limited conservation to part of the C-terminal of the
long MTf1 transcript (Fig. 2).
Examination of the protein product of the short MTf1
cDNA (Fig. 2) showed it to consist of 302 amino acids, while
the long MTf1 protein isoform was composed of 738 amino
acids. The short MTf1 isoform contains the ¢rst four of ¢ve
Fe-binding residues (DYRY at positions 78, 107, 136, and
210) found in the N-terminal lobe [1] (Fig. 2). The ¢fth coor-
dinating residue H (279) resides in exon 7, that does not form
part of the short MTf isoform (Fig. 2). This raises the ques-
tion of whether this latter molecule can bind Fe. In addition,
the consensus thermolysin metalloprotease sequence present
within the long MTf1 protein isoform [1] is absent in the short
isoform (Fig. 2).
Some molecules involved in Fe uptake (e.g. the Tf receptor)
are regulated by the binding of the iron regulatory proteins
(IRPs) to the iron-responsive elements (IREs) within the
UTRs [3]. Considering this, we examined the MTf1 transcripts
for the presence of the consensus IRE (5P-CAGUGN-3P) that
forms the loop of this motif [3]. In the long 2.6 kb MTf1
transcript and the short MTf1 transcript, the consensus IRE
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Table 1
MTf nucleotide and protein sequences in the GenBank database
GenBank accession no. bp aa Tissue type
Nucleotide ID Protein ID
Long MTf transcripts
M12154 AAA59992 2368 738 SK-MEL 28 melanoma
cell
NM_005929 NP_005920 2368 738 melanoma cells
XM_028282 XP_028282 2364 738 human
XM_028281 XP_028281 2607 738 human
Short MTf transcripts
NM_033316 NP_201573 1664 302 skin, melanotic melanoma
BC 022623 AAH02623 1659 302 uterus, endometrium-
adenocarcinoma
BC 001875 AAH01875 1664 302 skin, melanotic melanoma
BC 007550 AAH07550 1664 302 skin, melanotic melanoma
XM_003133 XP_003133 1629 302 human
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motif was present within the 3P-UTR. However, there was no
evidence that a stem could form to produce the typical stem-
loop structure of the IRE that is essential to bind IRPs [3].
Interestingly, using the computer program Sosui from the
Expert Protein Analysis System (ExPASy) [4], the short MTf1
transcript was predicted to produce a soluble protein. In ad-
dition, two programs from ExPASy (the big-PI Predictor and
DGPI) indicated there was no evidence that this short isoform
would be GPI-anchored. Hence, it can be suggested that the
short isoform may correspond to soluble MTf found in the
serum of patients with Alzheimer’s disease [2]. As a relevant
control, the long MTf1 transcripts were also assessed and
found to correctly predict a membrane-bound molecule at-
tached via a GPI anchor.
A ‘blast’ search of the human genome using the MTf1 tran-
scripts described above revealed a surprise, namely a second
MTf gene (tentatively called MTf2), directly adjacent to MTf1
on chromosome 3. Diagrammatic representation of the two
genes is shown in Fig. 1. MTf2 is remarkably similar to MTf1
in many respects, and may be the result of partial gene dupli-
cation. This tandem duplication was not observed for serum
Tf or lactoferrin. The MTf1 and MTf2 genes share the same
56 and 110 bp minimal enhancers and minimal promoter from
positions 3204 to 31 [5]. In addition, the MTf2 gene contains
exons 1^6, which are identical to the ¢rst six exons of MTf1.
Furthermore, the intervening intronic regions are exactly the
same. The region following exon 6 in MTf2 is composed of
702 bp of intronic sequence which is the same as that in
MTf1. After this latter intron, the sequence then strongly
deviates from that found in MTf1.
Similar to the short MTf1 transcript, only four of the ¢ve
high a⁄nity Fe-binding residues are present within the MTf2
gene, while the thermolysin metalloprotease consensus se-
quence found in the long MTf1 transcript [1] is absent from
MTf2. The lack of conservation of the Fe-binding site and
metalloprotease site suggests their redundancy.
The functions of the MTf1 protein isoforms and the puta-
tive MTf2 protein remain a mystery. While these molecules
show high homology to Tf, evidence to date has not impli-
cated a role for MTf in e⁄cient cellular Fe transport [1]. In-
Fig. 1. Schematic illustration showing the relative positions of the originally identi¢ed MTf1 gene compared to the newly identi¢ed MTf2 gene.
Three transcripts have been identi¢ed that originate from the MTf1 gene, that is, two ‘long’ transcripts and one ‘short’ transcript. Both long
transcripts (16 exons) encode the membrane-bound MTf1 molecule and di¡er from one another by an additional exon (16b). The short MTf1
transcript (six exons and exon 6b) may encode the soluble form of the protein that is found in Alzheimer’s disease [2]. The MTf2 gene consists
of six putative exons that are identical to those found in the MTf1 gene. Furthermore, the MTf2 gene has identical minimal enhancer (E) and
promoter (P) elements to those identi¢ed in MTf1, although a MTf2 transcript has not been reported.
Fig. 2. Sequence alignment of the short and long MTf1 protein iso-
forms from GenBank. The identical regions correspond to the ¢rst
six exons of the MTf1 gene, the end of which is indicated by #.
The boxes indicate conserved Fe-binding residues and the consensus
thermolysin metalloprotease site (LGHEYLHAMK) [1]. Notably,
the ¢fth Fe-binding residue H (279) and the thermolysin metallopro-
tease site are absent in the short isoform. It is also of interest that
the C-terminals of the short and long isoforms share some conserva-
tion. (*) identical, (:) conservation of residue type, (.) partial conser-
vation of residue type. Classi¢cation of amino acids is the same as
described by the CLUSTAL W Multiple Sequence Alignment Pro-
gram v. 1.8 (www.clustalw.genome.ad.jp/SIT/clustalw.html).
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deed, the fact that there is no conservation of the MTf Fe-
binding sites in the short MTf1 transcript, in MTf2, or in MTf
identi¢ed from other organisms, could suggest that it has
other functions [1]. However, the strong conservation of the
sequence in the ¢rst six exons suggests that this may be vital
for the biological function of MTf.
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